Intravenous antiarrhythmic drug therapy in the resuscitation from refractory ventricular arrhythmias

American Journal of Cardiology

Volumn 84, Issue 9 SUPPL. 1, 1999, Pages 52-55

  Kudenchuk, Peter J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BRETYLIUM; LIDOCAINE; MAGNESIUM; PLACEBO; PROCAINAMIDE;

CLINICAL TRIAL; CONFERENCE PAPER; DEFIBRILLATION; HEART ARREST; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; PRIORITY JOURNAL; RESUSCITATION; SURVIVAL RATE; TORSADE DES POINTES; UNITED STATES;

EID: 0032703766     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00703-1     Document Type: Conference Paper

References (48)

1. Weaver W.D., Cobb L.A., Hallstrom A.P., Copass M.K., Ray R., Emergy M., Fahrenbruch C. Considerations for improving survival from out-of-hospital cardiac arrest. Ann Emerg Med. 15:1986;1181-1186.
2. Valuenzela T.D., Roe D.J., Cretin S., Spaite D.W., Larsen M.P. Estimating effectiveness of cardiac arrest interventions a logistic regression survival model . Circulation. 96:1997;3308-3313.
3. Herlitz J., Ekstrom L., Wennerblom B., Axelsson A., Bang A., Holmberg S. Survival in patients found to have ventricular fibrillation after cardiac arrest witnessed outside hospital. Eur Heart J. 15:1994;1628-1633.
4. Cummins R.O. Advanced Cardiac Life Support. 1997;1-7 American Heart Association, Dallas, TX.
5. Cox S.V., Woodhouse S.P., Weber M., Boyd P., Case C. Rhythm changes during resuscitation from ventricular fibrillation. Resuscitation. 26:1993;53-61.
6. Cummins R.O. Advanced Cardiac Life Support. 1997;1-17 American Heart Association, Dallas, TX.
7. Guidelines for advanced life support: A statement by the Advanced Life Support Working Party of the European Resuscitation Council, 1992. Resuscitation 1992;24:111-121.
8. Weaver W.D. Resuscitation outside the hospital what's lacking . N Engl J Med. 325:1991;1437-1439.
9. Jaffe A.S. The use of antiarrhythmics in advanced cardiac life support. Ann Emerg Med. 22:1993;307-316.
10. Guidelines for advanced life support: A statement by the Advanced Life Support Working Party of the European Resuscitation Council, 1992. Resuscitation 1992;24:111-121.
11. Lown B., Fakhro A.M., Hood W.B., Thorn G.W. The coronary care unit, new perspectives and directions. JAMA. 199:1967;188-198.
12. Lie R.I., Wellens H.J., Van Capellie F.J. Lidocaine in the prevention of primary ventricular fibrillation a double-blind, randomized study of 212 consecutive patients . N Engl J Med. 219:1974;1324-1326.
13. Preliminary Report effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction . N Engl J Med. 321:1989;406-412.
14. MacMahon S., Collins R., Pete R. Effects of prophylactic lidocaine in suspected acute myocardial infarction an overview of results from randomized, controlled trials . JAMA. 260:1988;1910-1916.
15. Hine L.K., Laird N., Newitt P. Meta-analytic evidence against the prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med. 149:1989;2694-2698.
16. Lazzara R., El-Sherif N., Sherlag B.J. Electrophysiological properties of canine Purkinje fibers in one-day-old myocardial infarction. Circ Res. 33:1973;722-734.
17. Lazzara R., Hope R.R., El-Sherif N. Effects of lidocaine on hypoxic and ischemic cardiac cells. Am J Cardiol. 41:1978;872-879.
18. Hondeghem L.M. Selective depression of the ischemic and hypoxic myocardium by lidocaine. Proc West Pharmacol Soc. 18:1975;27-30.
19. Borer J.S., Harrison L.A., Kent K.M. Beneficial effect of lidocaine on ventricular electrical stability and spontaneous ventricular fibrillation during experimental myocardial infarction. Am J Cardiol. 37:1976;860-863.
20. Spear J.F., Moore E.N., Gerstenblith G. Effect of lidocaine on the ventricular fibrillation threshold in the dog during acute ischemia and premature ventricular contractions. Circulation. 46:1972;65-73.
21. Gilmore J.P., Siegel J.H. Mechanisms of the myocardial effects of bretylium. Circ Res. 10:1962;347-353.
22. Bigger J.T., Jaffe C.C. The effect of bretylium tosylate on the electrophysiologic properties of ventricular muscle and Purkinje fibers. Am J Cardiol. 27:1971;82-92.
23. Woske H., Belford J., Fastier F.N. The effect of procainamide on excitablity, refractoriness and conduction in the mammalian heart. J Pharm Exp Ther. 107:1953;134-140.
24. Kojima S., Wu S.T., Wilman-Coffelt J., Parmley W.W. Acute amiodarone terminates ventricular fibrillation by modifying cellular calcium homeostasis in isolated perfused rat hearts. J Pharm Exp Ther. 275:1995;254-262.
25. Kadish A., Morady F. The use of intravenous amiodarone in the acute therapy of life-threatening tachyarrhythmias. Prog Cardiovasc Dis. 31:1989;281-294.
26. Redding J.S., Pearson J.W. Evaluation of drugs for cardiac resuscitation. Anesthesiology. 24:1963;203-207.
27. Redding J.S., Pearson J.W. Resuscitation from ventricular fibrillation. JAMA. 203:1968;255-260.
28. Babbs C.F., Yim G.K., Whistler S.J., Tacker W.A., Geddes L.A. Elevation of ventricular defibrillation threshold in dogs by antiarrhythmic drugs. Am Heart J. 98:1979;345-350.
29. Yoon M.S., Han J., Goel B.G., Creamer P. Effect of procainamide on fibrillation threshold of normal and ischemic ventricles. Am J Cardiol. 33:1974;238-242.
30. Echt D.S., Black J.N., Barbey J.T., Coxe D.R., Cato E. Elevation of antiarrhythmic drugs on defibrillation energy requirements in dogs sodium channel block and action potential prolongation . Circulation. 76:1989;1106-1117.
31. Kerber R.E., Pandian N.G., Jensen S.R., Constantin L., Kieso R.A., Melton J., Hunt M. Effect of lidocaine on energy requirements for transthoracic defibrillation experimental studies . J Am Coll Cardiol. 7:1986;397-405.
32. Dorian P., Fain E.S., Davy J.M., Winkle R.A. Lidocaine causes a reversible, concentration-dependent increase in defibrillation energy requirements. J Am Coll Cardiol. 8:1986;327-332.
33. Tacker W.A. Jr, Niebauer M.J., Babbs C.F., Combs W.J., Hahn B.M., Barker M.A., Seipel J.F., Bourland J.D., Geddes L.A. The effect of newer antiarrhythymic drugs on defibrillation threshold. Crit Care Med. 8:1980;177-180.
34. Zhou L., Chen B.P., Kluger J., Fan C., Chow M.S.S. Effects of amiodarone and its active metabolite desethylamiodarone on ventricular defibrillation threshold. J Am Coll Cardiol. 31:1998;1672-1678.
35. Harrison E.E. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerg Med. 10:1981;420-423.
36. vanWalraven C., Stiell I.G., Wells G.A., Hebert P.C., Vandemheen K. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? Ann Emerg Med. 32:1998;544-553.
37. Herlitz J., Ekstrom L., Wennerblom B., Axelsson A., Bang A., Lindkvist J., Persson N.G., Holmberg S. Lidocaine in out of hospital ventricular fibrillation Does it improve survival? Resuscitation. 33:1997;199-205.
38. Weaver W.D., Fahrenbruch D.C.E., Johnson D.D., Hallstrom A.P., Cobb L.A., Copass M.K. Effect of epinephrine and lidocaine therapy on outcome after cardiac arrest due to ventricular fibrillation. Circulation. 82:1990;2027-2034.
39. Tzivoni D., Banai S., Schuger C., Benhorin J., Keren A., Gottlieb S., Stern S. Treatment of torsade de pointes with magnesium sulfate. Circulation. 77:1988;293-397.
40. Thel M.C., Armstrong A.L., McNulty S.E., Califf R.M., O'Connor C.M. Randomized trial of magnesium in in-hospital cardiac arrest. Lancet. 350:1997;1272-1276.
41. Fatovich D.M., Prentice D.A., Dobb G.J. Magnesium in cardiac arrest. Resuscitation. 35:1997;237-241.
42. Nowak R.M., Bodnar T.J., Dronen S., Gentzkow G., Tomlanovich M.C. Bretylium tosylate as initial treatment for cardiopulmonary arrest randomized comparison with placebo . Ann Emerg Med. 10:1981;404-407.
43. Haynes R.E., Chinn T.L., Copass J.K., Cobb L.A. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation a randomized clinical trial . Am J Cardiol. 48:1981;353-356.
44. Olson D.W., Thompson B.M., Darin J.C., Milbrath M.H. A randomized comparison study of bretylium tosylate and lidocaine in resuscitation of patients from out of hospital ventricular fibrillation in a paramedic system. Ann Emerg Med. 13:1984;807-810.
45. Anastaasio-Nana M.I., Nanas J.N., Nanas S.N., Rapti A., Poyadjis A., Stathaki S., Moulopoulos S.D. Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction an experimental study . J Am Coll Cardiol. 23:1994;253-258.
46. Scheinman M.M., Levine J.H., Cannom D.S., Freihling T., Kopelman H.A., Chilson D.A., Platia E.V., Wilber D.J., Kowey P.R. Dose ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. Circulation. 92:1995;3264-3272.
47. Kowey P.R., Levine J.H., Herre J.M., Pacifico A., Lindsay B.D., Plumb V.J., Janosik D.L., Kopelman H.A., Scheinman M.M. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent hemodynamically destabilizing ventricular tachycardia or fibrillation. Circulation. 92:1995;3255-3263.
48. Kudenchuk P.J., Cobb L.A., Copass M.K., Cummins R.O., Doherty A.M., Fahrenburch C.E., Hallstrom A.P., Murray W.A., Olsufka M., Walsh T. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med. 341:1999;871-887.